TYROSINE-PROTEIN KINASE SYK

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 12:05:23 UTC 2023` Edited by `admin` on `Sat Dec 16 12:05:23 UTC 2023`
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	JS20X60RRY
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TYROSINE-PROTEIN KINASE SYK

Common Name

English

SPLEEN TYROSINE KINASE

Common Name

English

SYK

Common Name

English

P72-SYK

Common Name

English

Code System Code Type Description

WIKIPEDIA

SYK

Created by admin on Sat Dec 16 12:05:24 UTC 2023 , Edited by admin on Sat Dec 16 12:05:24 UTC 2023

PRIMARY

UNIPROT

P43405

Created by admin on Sat Dec 16 12:05:24 UTC 2023 , Edited by admin on Sat Dec 16 12:05:24 UTC 2023

PRIMARY

FDA UNII

JS20X60RRY

Created by admin on Sat Dec 16 12:05:24 UTC 2023 , Edited by admin on Sat Dec 16 12:05:24 UTC 2023

PRIMARY

PHAROS

P43405

Created by admin on Sat Dec 16 12:05:24 UTC 2023 , Edited by admin on Sat Dec 16 12:05:24 UTC 2023

PRIMARY

Related Record Type Details


					Y4069R7J86

R-343

INHIBITOR -> TARGET

Amount:


					5YZ3QBQ97C

OXSI-2

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					8QR88H79VX

INHIBITOR -> TARGET

Comments:

Assessed by Invitrogen/Life Technologies using the Z’-LYTE assay format

Interaction Type:

REVERSIBLE

Qualification:

IC50

Amount:


					WF9CA8UL2V

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					C0WUS7XXE9

INHIBITOR -> TARGET

Amount:


					K9C42672RH

INHIBITOR -> TARGET

Amount:


					9CL6353KHO

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					OOA78Q9G2I

MK-8457

INHIBITOR -> TARGET

Comments:

Dropped from clinical trials because of adverse events probably bleeding.

Amount:


					Y7W5AL9KHB

R-112

INHIBITOR -> TARGET

Amount:


					H3W3QJ5C7G

CGP-62221

INHIBITOR -> TARGET

Amount:


					RC3A285J2G

TAMATINIB

INHIBITOR -> TARGET

Comments:

inhibited its kinase activity as an ATP-competitive inhibitor (Ki = 30 nM)

Interaction Type:

COMPETITIVE INHIBITOR

Qualification:

Ki

Amount:


					D9B1PJ9MWX

CGP-52421

INHIBITOR -> TARGET

Amount:


					6I3O3W6O3B

INHIBITOR -> TARGET

Amount:


					A6U64OU57E

INHIBITOR -> TARGET

Amount:


					3N3H8BX897

INHIBITOR -> TARGET

Amount:


					D1LXQ45S1O

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					4801QYW816

INHIBITOR -> TARGET

Amount:


					SQ8A3S5101

INHIBITOR -> TARGET

Amount:


					ID912S5VON

INHIBITOR -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT	CHEMICAL